BackEyebright Medical Technology (Beijing) , Ltd. Overview

Eyebright Medical Technology (Beijing) , Ltd. Profit Margin

Latest profit margin for Eyebright Medical Technology (Beijing) , Ltd.: 13.45% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

15.98%
↓ 25.62% YoY

As of Sep 2026

Annual Profit Margin (TTM)

13.45%
↓ 44.87% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Eyebright Medical Technology (Beijing) , Ltd. (688050.SS) FAQ

The latest profit margin for 688050.SS is 13.45% as of September 2026. That compares with 24.4% in the prior-year period — down 44.9% year over year. That is above the sector sector average of 13.4%. Investors often review this figure alongside Eyebright Medical Technology (Beijing) , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 688050.SS's profit margin moved from 24.4% to 13.45% — a 44.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eyebright Medical Technology (Beijing) , Ltd.'s valuation or profitability profile.

Against its sector companies, 688050.SS currently prints 13.45% for profit margin, while the sector average sits near 13.4%. That is roughly 0.4% above the sector mean. Large gaps often invite a closer look at Eyebright Medical Technology (Beijing) , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Eyebright Medical Technology (Beijing) , Ltd. converts resources into returns. At 13.45%, 688050.SS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 24.4% in the prior-year period — down 44.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 688050.SS's profit margin (13.45%), review year-over-year change from 24.4%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.